What is Alamar Biosciences 's net change in cash?

Alamar Biosciences (ALMR) reported net change in cash of $34.58M in Q1 2026.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Alamar Biosciences ALMR Net Change in Cash

Net Change in Cash at other companies

Akamai TechnologiesAKAM

-$304.37M-152%

BiogenBIIB

$392.2M+108%

UDRUDR

-$2.13M-1.3%

Vertiv Holdings CoVRT

$401.4M+64.6%

Henry ScheinHSIC

-$18M-460%

Keysight TechnologiesKEYS

$235M-77.8%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's net change in cash?: Alamar Biosciences (ALMR) reported net change in cash of $34.58M in Q1 2026.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.